The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
2012 · Nature · 8,295 citations
https://doi.org/10.1038/nature11003
J
Jordi Barretina
Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol(ES)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
152
Papers
32.6K
Citations
48
h-index
74
i10-index
Jordi Barretina is an academic researcher from Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Lung Cancer Treatments and Mutations & Esophageal Cancer Research and Treatment. The author has an h-index of 48, co-authored 130 publications.
ORCID: 0000-0002-3478-4080Papers by this author
worksFunctional genomics reveal that the serine synthesis pathway is essential in breast cancer
2011 · Nature · 1,706 citations
https://doi.org/10.1038/nature10350
An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules
2013 · Cell · 842 citations
https://doi.org/10.1016/j.cell.2013.08.003
Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K Signaling
2009 · Cancer Cell · 457 citations
https://doi.org/10.1016/j.ccr.2009.06.006
Differential sensitivity of melanoma cell lines with BRAF V600E mutation to the specific Raf inhibitor PLX4032
2010 · Journal of Translational Medicine · 224 citations
https://doi.org/10.1186/1479-5876-8-39
Functional Copy-Number Alterations in Cancer
2008 · PLoS ONE · 172 citations
https://doi.org/10.1371/journal.pone.0003179
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat